Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Is the Federal Circuit Playing with Fire?
Less than two months before the Supreme Court is scheduled to review the Federal Circuit's en banc decision in In re Bilski that found Bilski's business method claims unpatentable under 35 U.S.C. ' 101, the Federal Circuit held in Prometheus Labs., Inc. v. Mayo Collaborative Servs. (Fed. Cir. 2009) that claims to a diagnostic method are patent-eligible subject matter. The Federal Circuit reversed the district court's decision and held that Prometheus' personalized medicine claims satisfied the machine or transformation test set out in Bilski. 545 F.3d 943 (Fed. Cir. 2008) (en banc), cert. granted, argument set for Nov. 9, 2009. The timing of this decision cannot be overlooked. While the claims at issue in Bilski were drawn to business methods, many groups (as evidenced by the amicus briefs) are concerned that application of the strict machine or transformation test would render diagnostic and personalized medicine methods, particularly in the medical and biological fields, invalid and unpatentable under ' 101.
The court's decision in Classen Immunotherapies, Inc. v. Biogen Idec (Fed. Cir. 2008), rendered shortly after Bilski, turned the concern of those interested in patenting diagnostic methods into fear. Classen's claims were held invalid under ' 101 because the claims were neither tied to a particular machine nor did they transform a particular article into a different state or thing. The claim at issue was drawn to a method of determining whether an immunization schedule affects the incidence or severity of a chronic immune-related disorder. The claim recited immunizing mammals with immunogens according to a schedule and comparing the incidence, prevalence, frequency, or severity of the chronic immune-related disorder in the treatment group to a control group. The Classen decision seemed to indicate that the Federal Circuit would follow the views expressed in Justice Breyer's dissent in Laboratory Corp. v. Metabolite Labs., Inc. 548 U.S. __ (2006) (“LabCorp“) in which he criticizes the scope of claims directed to identifying a vitamin deficiency based on measuring increased levels of homocysteine in blood. The patent eligibility of diagnostic or personalized medicine methods was uncertain.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Bankruptcy Sales: Finding a Diamond In the Rough
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Law Firms are Reducing Redundant Real Estate by Bringing Support Services Back to the Office
A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.
Bit Parts
Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights
Risks of “Baseball Arbitration” in Resolving Real Estate Disputes
“Baseball arbitration” refers to the process used in Major League Baseball in which if an eligible player's representative and the club ownership cannot reach a compensation agreement through negotiation, each party enters a final submission and during a formal hearing each side — player and management — presents its case and then the designated panel of arbitrators chooses one of the salary bids with no other result being allowed. This method has become increasingly popular even beyond the sport of baseball.
One Overlooked Element of Executive Safety: Data Privacy
Executives have access to some of the company's most sensitive information, and they're increasingly being targeted by hackers looking to steal company secrets or to perpetrate cybercrimes.